{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T10:53:04Z","timestamp":1784371984831,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T00:00:00Z","timestamp":1523491200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Chinese Natural Science Fund","award":["81671037"],"award-info":[{"award-number":["81671037"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s12028-018-0536-6","type":"journal-article","created":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T19:14:37Z","timestamp":1523560477000},"page":"264-272","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Clinical Characteristics and Prognosis of Severe Anti-N-methyl-d-aspartate Receptor Encephalitis Patients"],"prefix":"10.1007","volume":"29","author":[{"given":"Yan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbo","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,12]]},"reference":[{"key":"536_CR1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12:157\u201365.","journal-title":"Lancet Neurol"},{"key":"536_CR2","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1007\/s10072-016-2702-y","volume":"37","author":"X Chen","year":"2016","unstructured":"Chen X, Li JM, Liu F, et al. Anti-N-methyl-d-aspartate receptor encephalitis: a common cause of encephalitis in the intensive care unit. Neurol Sci. 2016;37:1993\u20138.","journal-title":"Neurol Sci"},{"key":"536_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2169\/internalmedicine.54.2047","volume":"54","author":"M Kadoya","year":"2015","unstructured":"Kadoya M, Onoue H, Kadoya A, et al. Refractory status epilepticus caused by anti-NMDA receptor encephalitis that markedly improved following combination therapy with rituximab and cyclophosphamide. Intern Med. 2015;54:209\u201313.","journal-title":"Intern Med"},{"key":"536_CR4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/jca.21363","volume":"30","author":"AD DeSena","year":"2015","unstructured":"DeSena AD, Noland DK, Matevosyan K, et al. Intravenous methylprednisolone versus therapeutic plasma exchange for treatment of anti-N-methyl-d-aspartate receptor antibody encephalitis: a retrospective review. J Clin Apher. 2015;30:212\u20136.","journal-title":"J Clin Apher"},{"key":"536_CR5","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3892\/etm.2014.1849","volume":"8","author":"B Chen","year":"2014","unstructured":"Chen B, Wang Y, Geng Y, et al. Marked improvement of anti-N-methyl-d-aspartate receptor encephalitis by large-dose methylprednisolone and plasmapheresis therapy combined with F-fluorodeoxyglucose positron emission tomography imaging: a case report. Exp Ther Med. 2014;8:1167\u20139.","journal-title":"Exp Ther Med"},{"key":"536_CR6","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/ane.12723","volume":"136","author":"X Chi","year":"2017","unstructured":"Chi X, Wang W, Huang C, et al. Risk factors for mortality in patients with anti-NMDA receptor encephalitis. Acta Neurol Scand. 2017;136:298\u2013304.","journal-title":"Acta Neurol Scand"},{"key":"536_CR7","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s12028-015-0196-8","volume":"24","author":"MK Mittal","year":"2016","unstructured":"Mittal MK, Rabinstein AA, Hocker SE, et al. Autoimmune encephalitis in the ICU: analysis of phenotypes, serologic findings, and outcomes. Neurocrit Care. 2016;24:240\u201350.","journal-title":"Neurocrit Care"},{"key":"536_CR8","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3389\/fimmu.2017.00835","volume":"8","author":"G Harutyunyan","year":"2017","unstructured":"Harutyunyan G, Hauer L, Dunser MW, et al. Risk factors for intensive care unit admission in patients with autoimmune encephalitis. Front Immunol. 2017;8:835.","journal-title":"Front Immunol"},{"key":"536_CR9","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s12028-015-0196-8","volume":"24","author":"MK Mittal","year":"2016","unstructured":"Mittal MK, Rabinstein AA, Hocker SE, et al. Autoimmune encephalitis in the ICU: analysis of phenotypes, serologic findings, and outcomes. Neurocrit Care. 2016;24:240\u201350.","journal-title":"Neurocrit Care"},{"key":"536_CR10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15:391\u2013404.","journal-title":"Lancet Neurol"},{"key":"536_CR11","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.clinph.2017.04.015","volume":"128","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Liu G, Jiang MD, et al. Analysis of electroencephalogram characteristics of anti-NMDA receptor encephalitis patients in China. Clin Neurophysiol. 2017;128:1227\u201333.","journal-title":"Clin Neurophysiol"},{"key":"536_CR12","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1177\/0883073813515947","volume":"30","author":"M Nosadini","year":"2015","unstructured":"Nosadini M, Boniver C, Zuliani L, et al. Longitudinal electroencephalographic (EEG) findings in pediatric anti-N-methyl-d-aspartate (anti-NMDA) receptor encephalitis: the Padua experience. J Child Neurol. 2015;30:238\u201345.","journal-title":"J Child Neurol"},{"key":"536_CR13","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1212\/WNL.0000000000001940","volume":"85","author":"N Gaspard","year":"2015","unstructured":"Gaspard N, Foreman BP, Alvarez V, et al. New-onset refractory status epilepticus: etiology, clinical features, and outcome. Neurology. 2015;85:1604\u201313.","journal-title":"Neurology"},{"key":"536_CR14","doi-asserted-by":"publisher","first-page":"e4365","DOI":"10.1097\/MD.0000000000004365","volume":"95","author":"BC Duan","year":"2016","unstructured":"Duan BC, Weng WC, Lin KL, et al. Variations of movement disorders in anti-N-methyl-d-aspartate receptor encephalitis: a nationwide study in Taiwan. Medicine (Baltimore). 2016;95:e4365.","journal-title":"Medicine (Baltimore)"},{"key":"536_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.neucli.2015.12.009","volume":"46","author":"E Chanson","year":"2016","unstructured":"Chanson E, Bicilli E, Lauxerois M, et al. Anti-NMDA-R encephalitis: should we consider extreme delta brush as electrical status epilepticus? Neurophysiol Clin. 2016;46:17\u201325.","journal-title":"Neurophysiol Clin"},{"key":"536_CR16","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1378\/chest.13-1490","volume":"145","author":"CM Howard","year":"2014","unstructured":"Howard CM, Kass JS, Bandi VD, et al. Challenges in providing critical care for patients with anti-N-methyl-d-aspartate receptor encephalitis. Chest. 2014;145:1143\u20137.","journal-title":"Chest"},{"key":"536_CR17","first-page":"7967526","volume":"2016","author":"SR Mehr","year":"2016","unstructured":"Mehr SR, Neeley RC, Wiley M, et al. Profound autonomic instability complicated by multiple episodes of cardiac asystole and refractory bradycardia in a patient with anti-NMDA encephalitis. Case Rep Neurol Med. 2016;2016:7967526.","journal-title":"Case Rep Neurol Med"},{"key":"536_CR18","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1016\/j.jocn.2011.03.024","volume":"18","author":"M Lee","year":"2011","unstructured":"Lee M, Lawn N, Prentice D, et al. Anti-NMDA receptor encephalitis associated with ictal asystole. J Clin Neurosci. 2011;18:1716\u20138.","journal-title":"J Clin Neurosci"},{"key":"536_CR19","doi-asserted-by":"publisher","first-page":"803","DOI":"10.2169\/internalmedicine.49.3221","volume":"49","author":"Y Taguchi","year":"2010","unstructured":"Taguchi Y, Takashima S, Nukui T, et al. Hypersalivation in a patient with anti-NMDAR encephalitis with ovarian teratoma. Intern Med. 2010;49:803\u20134.","journal-title":"Intern Med"},{"key":"536_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.resp.2005.03.009","volume":"149","author":"KA Waters","year":"2005","unstructured":"Waters KA, Machaalani R. Role of NMDA receptors in development of respiratory control. Respir Physiol Neurobiol. 2005;149:123\u201330.","journal-title":"Respir Physiol Neurobiol"},{"key":"536_CR21","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.neuroscience.2010.09.055","volume":"171","author":"Q Liu","year":"2010","unstructured":"Liu Q, Wong-Riley MT. Postnatal development of N-methyl-d-aspartate receptor subunits 2A, 2B, 2C, 2D, and 3B immunoreactivity in brain stem respiratory nuclei of the rat. Neuroscience. 2010;171:637\u201354.","journal-title":"Neuroscience"},{"key":"536_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.seizure.2015.04.005","volume":"29","author":"R Wang","year":"2015","unstructured":"Wang R, Guan HZ, Ren HT, et al. CSF findings in patients with anti-N-methyl-d-aspartate receptor-encephalitis. Seizure. 2015;29:137\u201342.","journal-title":"Seizure"},{"key":"536_CR23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","volume":"13","author":"N Gresa-Arribas","year":"2014","unstructured":"Gresa-Arribas N, Titulaer MJ, Torrents A, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol. 2014;13:167\u201377.","journal-title":"Lancet Neurol"},{"issue":"9","key":"536_CR24","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1708712","volume":"378","author":"J Dalmau","year":"2018","unstructured":"Dalmau J, Graus F. Antibody-mediated encephalitis. N Engl J Med. 2018;378(9):840\u201351.","journal-title":"N Engl J Med"},{"key":"536_CR25","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/j.clinph.2014.01.001","volume":"125","author":"SF Da","year":"2014","unstructured":"Da SF, Castro LH, Andrade JQ, et al. Serial and prolonged EEG monitoring in anti-N-methyl-d-aspartate receptor encephalitis. Clin Neurophysiol. 2014;125:1541\u20134.","journal-title":"Clin Neurophysiol"},{"key":"536_CR26","doi-asserted-by":"publisher","first-page":"2701526","DOI":"10.1155\/2016\/2701526","volume":"2016","author":"FJ Carvajal","year":"2016","unstructured":"Carvajal FJ, Mattison HA, Cerpa W. Role of NMDA receptor-mediated glutamatergic signaling in chronic and acute neuropathologies. Neural Plast. 2016;2016:2701526.","journal-title":"Neural Plast"},{"key":"536_CR27","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.clinph.2014.11.006","volume":"126","author":"R Sutter","year":"2015","unstructured":"Sutter R, Kaplan PW, Cervenka MC, et al. Electroencephalography for diagnosis and prognosis of acute encephalitis. Clin Neurophysiol. 2015;126:1524\u201331.","journal-title":"Clin Neurophysiol"},{"key":"536_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","volume":"10","author":"J Dalmau","year":"2011","unstructured":"Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10:63\u201374.","journal-title":"Lancet Neurol"},{"key":"536_CR29","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.jpeds.2012.10.011","volume":"162","author":"T Armangue","year":"2013","unstructured":"Armangue T, Titulaer MJ, Malaga I, et al. Pediatric anti-N-methyl-d-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients. J Pediatr. 2013;162:850\u20136.","journal-title":"J Pediatr"},{"key":"536_CR30","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.braindev.2016.01.009","volume":"38","author":"A Suppiej","year":"2016","unstructured":"Suppiej A, Nosadini M, Zuliani L, et al. Plasma exchange in pediatric anti-NMDAR encephalitis: a systematic review. Brain Dev. 2016;38:613\u201322.","journal-title":"Brain Dev"},{"key":"536_CR31","doi-asserted-by":"publisher","first-page":"845","DOI":"10.3892\/mco.2016.1054","volume":"5","author":"E Rypulak","year":"2016","unstructured":"Rypulak E, Borys M, Piwowarczyk P, et al. Successful treatment of anti-NMDA receptor encephalitis with a prompt ovarian tumour removal and prolonged course of plasmapheresis: a case report. Mol Clin Oncol. 2016;5:845\u20139.","journal-title":"Mol Clin Oncol"},{"key":"536_CR32","first-page":"1","volume":"2015","author":"L Shahani","year":"2015","unstructured":"Shahani L. Steroid unresponsive anti-NMDA receptor encephalitis during pregnancy successfully treated with plasmapheresis. BMJ Case Rep. 2015;2015:1\u20133.","journal-title":"BMJ Case Rep"},{"key":"536_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1192\/pb.bp.113.045518","volume":"39","author":"H Barry","year":"2015","unstructured":"Barry H, Byrne S, Barrett E, et al. Anti-N-methyl-d-aspartate receptor encephalitis: review of clinical presentation, diagnosis and treatment. BJPsych Bull. 2015;39:19\u201323.","journal-title":"BJPsych Bull"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12028-018-0536-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-018-0536-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-018-0536-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T00:25:37Z","timestamp":1555028737000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12028-018-0536-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,12]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["536"],"URL":"https:\/\/doi.org\/10.1007\/s12028-018-0536-6","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,12]]},"assertion":[{"value":"12 April 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}